The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life

被引:82
作者
Abayomi, J. [1 ,2 ]
Kirwan, J. [2 ]
Hackett, A. [1 ]
机构
[1] Liverpool John Moores Univ, Fac Educ Community & Leisure, Liverpool L17 6BD, Merseyside, England
[2] Liverpool Womens Hosp, Liverpool, Merseyside, England
关键词
Chronic radiation enteritis; Quality of life; Cervical cancer; Endometrial cancer; GASTROINTESTINAL SYMPTOMS; QUESTIONNAIRE; INCONTINENCE;
D O I
10.1016/j.ejon.2009.02.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
d Background: Studies suggest that 50% of people may suffer from chronic radiation enteritis (CRE) (Andreyev, J., 2005. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 54, 1051-1054). Gami et al. (Gami, B., Harrington, K., Blake, P., Dearnaley, D., Andreyev, H.J.N., 2003. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Alimentary Pharmacology and Therapeutics 18, 987-994) argue that this is unimportant if quality of life is unaffected. The aim of this study was to identify how many women experience CRE following radiotherapy and to investigate whether women who have higher doses of radiotherapy or more advanced stage of cancer are more at risk. Methods: Women (=117) who had completed radiotherapy for cervical or endometrial cancer were asked to complete a validated questionnaire exploring bowel problems and quality of life. Responses were scored and compared to scores for women with known faecal incontinence (Bugg, G.J., Kiff, E.S., Hosker, G., 2001. A new condition-specific health-related quality of life questionnaire for the assessment of women with anal incontinence. British journal of Obstetrics and Gynaecology 108 (10). 1057-1067). Results: Using a score of '0' to indicate no symptoms, 47% of women gained scores indicative of CRE (>0), range 20-85 (mean 34, SD 14.4). Younger women (p < 0.001) and women with cervical cancer (p < 0.05) were more likely to score for CRE. No significant relationship was observed between score and either radiotherapy dose or stage of cancer. Conclusions: Scoring suggests that about half of woman treated with radiotherapy develop CRE. Quality of life is affected, particularly regarding tiredness and coping behaviours due to lack of warning signs for CRE. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 21 条
[1]   A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer [J].
Abayomi, J ;
Kirwan, J ;
Hackett, A ;
Bagnall, G .
JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2005, 18 (05) :353-363
[2]   Gastrointestinal complications of pelvic radiotherapy: are they of any importance? [J].
Andreyev, J .
GUT, 2005, 54 (08) :1051-1054
[3]   Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients [J].
Andreyev, Jervoise .
LANCET ONCOLOGY, 2007, 8 (11) :1007-1017
[4]  
Bugg GJ, 2001, BRIT J OBSTET GYNAEC, V108, P1057, DOI 10.1016/S0306-5456(01)00245-5
[5]   Short report: A morbidity scoring system for clinical oncology practice: Questionnaires produced from the LENT SOMA scoring system [J].
Davidson, SE ;
Burns, M ;
Routledge, J ;
West, CML ;
Swindell, R ;
Logue, JP ;
Wylie, J ;
Slevin, NJ ;
Cowan, RA ;
Magee, B ;
Harris, MA .
CLINICAL ONCOLOGY, 2002, 14 (01) :68-69
[6]   Systematic review for non-surgical interventions for the management of late radiation proctitis [J].
Denton, AS ;
Andreyev, HJN ;
Forbes, A ;
Maher, EJ .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :134-143
[7]   The psychological impact of a cancer diagnosis on families: The influence of family functioning and patients' illness characteristics on depression and anxiety [J].
Edwards, B ;
Clarke, V .
PSYCHO-ONCOLOGY, 2004, 13 (08) :562-576
[8]  
Faithfull S, 1995, Eur J Cancer Care (Engl), V4, P158, DOI 10.1111/j.1365-2354.1995.tb00087.x
[9]   How patients manage gastrointestinal symptoms after pelvic radiotherapy [J].
Gami, B ;
Harrington, K ;
Blake, P ;
Dearnaley, D ;
Tait, D ;
Davies, J ;
Norman, AR ;
Andreyev, HJN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (10) :987-994
[10]  
GOODE C, 2006, CLIN ONCOLOGY, V18, P421